Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles A. Rowland Jr currently holds 20,400 shares of Orchard Therapeutics plc (ORTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles A. Rowland Jr has been a net seller of ORTX stock. They have purchased $2.4M and sold $9.8M worth of shares.
Charles A. Rowland Jr's most recent insider trade was on Jan 2, 2026, when they sold 20,400 shares at $0.00 per share.
Charles A. Rowland Jr serves as Executive at Orchard Therapeutics plc (ORTX). They have executed 80 insider transactions totaling $12.3M over their tenure at the company.
Charles A. Rowland Jr holds the position of Executive at Orchard Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Charles A. Rowland Jr has shown a selling trading pattern, with $2.4M in total purchases and $9.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles A. Rowland Jr was on Jan 24, 2014, when they sold $4.4M worth of VPHM shares. This transaction involved 87,026 shares at $50.00 per share.
Charles A. Rowland Jr currently owns 20,400 shares of Orchard Therapeutics plc (ORTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles A. Rowland Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles A. Rowland Jr has 80 Form 4 filings on record as an insider at Orchard Therapeutics plc.
Set alerts for Charles A. Rowland Jr and 40,000+ other insiders.